Mesoblast company info

What does Mesoblast do?
Mesoblast (ASX:MSB) is an Australian cell therapy company focused on the development and commercialization of cell therapy products for a range of diseases. The company's operations are focused on the manufacturing of cell therapy products, clinical trials of cell therapy products, regulatory approval of cell therapy products, and commercialisation of cell therapy products. Mesoblast's objective is to become a leading cell therapy company in the world.
Mesoblast company media
Company Snapshot

Is Mesoblast a public or private company?

key
Ownership
Public

How many people does Mesoblast employ?

people
Employees
83

What sector is Mesoblast in?

pie chart
Sector
Health Care

Where is the head office for Mesoblast?

location pin
Head Office
Melbourne, Australia

What year was Mesoblast founded?

founded flag
Year Founded
2004
What does Mesoblast specialise in?
/Pharmaceutical /Medical /Healthcare /Medtech /Biotech /Health

What are the products and/or services of Mesoblast?

Overview of Mesoblast offerings
Cell therapy development and commercialisation: Mesoblast develops and commercialises cell therapy products for a range of diseases, including acute respiratory distress syndrome, chronic heart failure, and severe burns.
Manufacturing of cell therapy products: Mesoblast manufactures cell therapy products at its state-of-the-art manufacturing facility in Victoria, Australia.
Clinical trials of cell therapy products: Mesoblast conducts clinical trials of its cell therapy products to assess their safety and efficacy in humans.
Regulatory approval of cell therapy products: Mesoblast works with regulatory authorities around the world to obtain regulatory approval for its cell therapy products.
Commercialisation of cell therapy products: Mesoblast commercialises its cell therapy products to patients in need.
Collaboration with other companies: Mesoblast collaborates with other companies to develop and commercialise cell therapy products.

Who is in the executive team of Mesoblast?

Mesoblast leadership team
  • Dr. Silviu  Itescu FACP, FACRA, FRACP, MBBS (Hons)
    Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)
    Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director
  • Dr. Eric A. Rose M.D.
    Dr. Eric A. Rose M.D.
    Chief Medical Officer & Executive Director
  • Mr. Andrew  Chaponnel B.Com.
    Mr. Andrew Chaponnel B.Com.
    Interim Chief Finance Officer
  • Mr. Peter T. Howard B.Sc., L.L.B., LLB (Hons)
    Mr. Peter T. Howard B.Sc., L.L.B., LLB (Hons)
    General Counsel & Corporate Executive
  • Mr. Roger D. Brown BA
    Mr. Roger D. Brown BA
    Head of Spinal Orthopedic Disorders
  • Mr. Michael  Schuster BSc, M.B.A., MS
    Mr. Michael Schuster BSc, M.B.A., MS
    Head of Pharma Partnering
  • Ms. Geraldine  Storton B.Sc., M.B.A., MMS
    Ms. Geraldine Storton B.Sc., M.B.A., MMS
    Head of Regulatory Affairs & Quality Management
  • Mr. Justin  Horst B.S.
    Mr. Justin Horst B.S.
    Head of Manufacturing